Fonar (FONR) Competitors $15.14 -0.37 (-2.39%) Closing price 04:00 PM EasternExtended Trading$15.10 -0.04 (-0.26%) As of 04:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FONR vs. DCTH, DRTS, SKIN, NPCE, SMTI, SNWV, TCMD, BWAY, CLPT, and CATXShould you be buying Fonar stock or one of its competitors? The main competitors of Fonar include Delcath Systems (DCTH), Alpha Tau Medical (DRTS), Beauty Health (SKIN), NeuroPace (NPCE), Sanara MedTech (SMTI), Sanuwave Health (SNWV), Tactile Systems Technology (TCMD), Brainsway (BWAY), ClearPoint Neuro (CLPT), and Perspective Therapeutics (CATX). These companies are all part of the "medical equipment" industry. Fonar vs. Its Competitors Delcath Systems Alpha Tau Medical Beauty Health NeuroPace Sanara MedTech Sanuwave Health Tactile Systems Technology Brainsway ClearPoint Neuro Perspective Therapeutics Delcath Systems (NASDAQ:DCTH) and Fonar (NASDAQ:FONR) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership, risk and media sentiment. Do analysts rate DCTH or FONR? Delcath Systems presently has a consensus target price of $24.50, indicating a potential upside of 112.31%. Given Delcath Systems' stronger consensus rating and higher possible upside, analysts clearly believe Delcath Systems is more favorable than Fonar.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Delcath Systems 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Fonar 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility and risk, DCTH or FONR? Delcath Systems has a beta of 0.85, indicating that its share price is 15% less volatile than the S&P 500. Comparatively, Fonar has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500. Is DCTH or FONR more profitable? Fonar has a net margin of 8.19% compared to Delcath Systems' net margin of 3.18%. Delcath Systems' return on equity of 6.91% beat Fonar's return on equity.Company Net Margins Return on Equity Return on Assets Delcath Systems3.18% 6.91% 5.80% Fonar 8.19%5.31%3.97% Which has better valuation & earnings, DCTH or FONR? Fonar has higher revenue and earnings than Delcath Systems. Fonar is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDelcath Systems$70.24M5.75-$26.39M$0.05230.80Fonar$102.88M0.91$10.57M$1.2512.11 Does the media favor DCTH or FONR? In the previous week, Fonar had 1 more articles in the media than Delcath Systems. MarketBeat recorded 2 mentions for Fonar and 1 mentions for Delcath Systems. Fonar's average media sentiment score of 0.09 beat Delcath Systems' score of 0.00 indicating that Fonar is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delcath Systems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Fonar 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders believe in DCTH or FONR? 61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 50.6% of Fonar shares are held by institutional investors. 17.4% of Delcath Systems shares are held by company insiders. Comparatively, 1.6% of Fonar shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryDelcath Systems beats Fonar on 9 of the 16 factors compared between the two stocks. Get Fonar News Delivered to You Automatically Sign up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FONR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FONR vs. The Competition Export to ExcelMetricFonarMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$93.87M$10.56B$5.75B$10.42BDividend YieldN/A1.88%5.74%4.63%P/E Ratio12.1121.2676.5526.74Price / Sales0.9131.42494.58162.18Price / Cash5.0024.4337.1760.63Price / Book0.613.4213.726.40Net Income$10.57M$210.63M$3.29B$271.71M7 Day Performance-3.51%-0.02%1.03%2.85%1 Month Performance0.20%2.67%6.32%9.64%1 Year Performance-12.99%-9.96%81.16%31.62% Fonar Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FONRFonar1.1239 of 5 stars$15.14-2.4%N/A-10.9%$93.87M$102.88M12.11480Upcoming EarningsDCTHDelcath Systems2.344 of 5 stars$10.83+1.5%$24.50+126.2%+29.8%$377.66M$70.24M215.9260DRTSAlpha Tau Medical1.6532 of 5 stars$3.86+0.1%$9.00+133.5%+63.5%$326.98MN/A-8.0380SKINBeauty Health1.78 of 5 stars$2.54-3.6%$2.63+3.6%+57.0%$325.29M$334.30M-9.161,030Trending NewsAnalyst ForecastNPCENeuroPace3.175 of 5 stars$9.70-1.3%$16.60+71.2%+51.3%$321.54M$79.91M-11.57170Positive NewsSMTISanara MedTech2.0663 of 5 stars$35.08+0.2%$50.00+42.5%+11.3%$312.25M$97.24M-30.2460SNWVSanuwave Health2.3623 of 5 stars$35.66+0.3%$55.00+54.2%N/A$305.61M$32.63M-4.3240TCMDTactile Systems Technology2.5151 of 5 stars$13.64+0.9%$13.50-1.0%+2.3%$304.70M$292.98M22.051,037Positive NewsBWAYBrainsway3.2315 of 5 stars$15.97+5.7%$18.00+12.7%+90.0%$301.68M$46.08M61.39120CLPTClearPoint Neuro1.5738 of 5 stars$10.42-0.5%$19.67+88.7%-2.7%$296.24M$31.39M-12.86110CATXPerspective Therapeutics2.1141 of 5 stars$3.49-2.8%$12.56+259.8%-75.4%$259.92MN/A0.0070Analyst Forecast Related Companies and Tools Related Companies Delcath Systems Competitors Alpha Tau Medical Competitors Beauty Health Competitors NeuroPace Competitors Sanara MedTech Competitors Sanuwave Health Competitors Tactile Systems Technology Competitors Brainsway Competitors ClearPoint Neuro Competitors Perspective Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FONR) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fonar Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Fonar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FONR Stock Alerts